Logan, A C <br/><br/>
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.  [electronic resource] 

 -  Leukemia  Aug 2013 
 - 1659-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2013.52  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Female<br/>Follow-Up Studies<br/>Hematopoietic Stem Cell Transplantation<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Immunoglobulin Heavy Chains--genetics<br/>Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual--diagnosis<br/>Prognosis<br/>Recurrence<br/>Reproducibility of Results<br/>Time Factors